CClinicalTrials.gg
CompletedNCT05176340Updated Jan 4, 2022

Action Modules on Resilience and Psychological Health

An interventional study of Specific Thematic Nursing Care Action Modules (STNC-AM) in Stroke Patients, sponsored by Chung Shan Medical University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-04.

Sponsored by Chung Shan Medical University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Aug 2019, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Non-randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

This study aimed to determine whether interventions that use the Specific Thematic Nursing Care Action Modules (STNC-AM) platform improve patients' psychological health over a two-month period.

Read the detailed description

The STNC-AM platform that investigator present here is an educational program that integrates education and coaching. STNC-AM has six key aspects: stroke prevention, management of emotions, management of fatigue, physical activity, caregiver training, and integrative resources. Each scope contains detailed care guidance. The nurse coaching component was based on the six key aspects detailed above. This online platform can guide nurses' health education for the comprehensive care of stroke patients.

02

Conditions studied

  • Stroke Patients

Browse trials for

Keywords

  • anxiety
  • depression
  • resilience
  • illness representation
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Chung Shan Medical University is the lead sponsor of 124 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • remaining hospitalized within 6 months after a stroke attack.
  • being able to communicate verbally.
  • being willing to participate.

Exclusion criteria

Exclusion Criteria:

  • Aphasia
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Intervention group

    Participants in the experimental group were provided an education program through the Care Action Module during their hospitalization period, and follow-up was conducted one and two months after discharge.

    Other: Specific Thematic Nursing Care Action Modules (STNC-AM)

  • No intervention
    Control group

    The control group received no intervention, except for the regular care followed by the nurses in general in the rehabilitation ward.

Interventions

  • OtherSpecific Thematic Nursing Care Action Modules (STNC-AM)

    The STNC-AM platform that investigators present here is an educational program that integrates education and coaching. The nurse coaching component was based on the STNC-AM platform. This online platform can guide nurses' health education for the comprehensive care of stroke patients. Nurses can use an iPad and enter the STNC-AM platform website, where they can directly access the Care Action Module.

06

What researchers measure

Primary outcomes

  1. Illness Perception_change is being assessed

    Investigators used the Illness Perception Questionnaire-Revised (IPQ-R) to evaluate stroke patients' positive illness representation. Investigators used the three positive domains (personal control, treatment control, and illness coherence) of illness representation to evaluate stroke patients' positive illness representation. Total scores ranged from 16 to 80 in each domain. High scores on all three dimensions (personal control, treatment control, and illness coherence) indicated a more positive illness representation.

    Time frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.

  2. Depression and Anxiety_change is being assessed

    Investigators used the Hospital Anxiety and Depression Scale (HADS) to evaluate stroke patients' depression and anxiety.Total scores ranged from 0 to 21 in each domain, and higher scores indicated higher anxiety or depression.

    Time frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.

  3. Resilience_change is being assessed

    Investigators used the Resilience Scale (RS) to evaluate stroke patients' resilience.Total scores ranged from 25 to 175, with higher scores as indicating greater resilience

    Time frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.

07

Study locations

1 site
  • Chung Shan Medical University
    Taichung, 40201, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05176340
Lead sponsor
Chung Shan Medical University
Responsible party
Hsiang Chu Pai (Principal Investigator, Chung Shan Medical University) — Principal investigator
First posted
Jan 4, 2022
Start date
Aug 1, 2019
Primary completion
Aug 1, 2019
Completion
Feb 28, 2021
Last update
Jan 4, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion